These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 29066124)
1. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities. Lo A; Ayre G; Ma R; Hsu F; Akagami R; McKenzie M; Valev B; Gete E; Vallieres I; Nichol A Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):443-451. PubMed ID: 29066124 [TBL] [Abstract][Full Text] [Related]
2. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience. Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381 [TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation. Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183 [TBL] [Abstract][Full Text] [Related]
4. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma. Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587 [TBL] [Abstract][Full Text] [Related]
5. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level. van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739 [TBL] [Abstract][Full Text] [Related]
7. Symptomatic outcomes in relation to tumor expansion after fractionated stereotactic radiation therapy for vestibular schwannomas: single-institutional long-term experience. Aoyama H; Onodera S; Takeichi N; Onimaru R; Terasaka S; Sawamura Y; Shirato H Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):329-34. PubMed ID: 22704983 [TBL] [Abstract][Full Text] [Related]
8. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy. Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496 [TBL] [Abstract][Full Text] [Related]
9. Audiologic and treatment outcomes after linear accelerator-based stereotactic irradiation for acoustic neuroma. Chung HT; Ma R; Toyota B; Clark B; Robar J; McKenzie M Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1116-21. PubMed ID: 15234046 [TBL] [Abstract][Full Text] [Related]
10. Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: a preliminary report. Poen JC; Golby AJ; Forster KM; Martin DP; Chinn DM; Hancock SL; Adler JR Neurosurgery; 1999 Dec; 45(6):1299-305; discussion 1305-7. PubMed ID: 10598696 [TBL] [Abstract][Full Text] [Related]
12. Hearing Outcomes After Stereotactic Radiosurgery for Vestibular Schwannomas : Mechanism of Hearing Loss and How to Preserve Hearing. Han JH; Kim DG; Chung HT; Paek SH; Jung HW Adv Tech Stand Neurosurg; 2016; (43):3-36. PubMed ID: 26508404 [TBL] [Abstract][Full Text] [Related]